Anhedonia as a Phenotype for the Val158Met COMT Polymorphism in Relatives of Patients With Schizophrenia

Journal of Abnormal Psychology

Volumn 117, Issue 4, 2008, Pages 788-798

  Docherty, Anna R ^a,b   Sponheim, Scott R ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

anhedonia; catechol O methyltransferase (COMT); phenotype; schizophrenia; schizotypy

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ALLELE; ANHEDONIA; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; QUESTIONNAIRE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SELF REPORT; SOCIAL INTERACTION; AGED; EMOTIONAL DISORDER; GENETIC POLYMORPHISM; GENETICS; HOMOZYGOTE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOSIS; SCHIZOTYPAL PERSONALITY DISORDER;

ADULT; AFFECTIVE SYMPTOMS; AGED; ALLELES; BIPOLAR DISORDER; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; METHIONINE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER; VALINE;

EID: 56849104488     PISSN: 0021843X     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0013745     Document Type: Article

References (80)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed., rev. (1987), Author, Washington, DC
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), Author, Washington, DC
3. Avramopoulos D., Stefanis N.C., Hantoumi I., Smyrnis N., Evdokimidis I., and Stefanis C.N. Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele. Molecular Psychiatry 7 (2002) 706-711
4. Badner J.A., and Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Molecular Psychiatry 7 (2002) 405-411
5. Berenbaum H., and McGrew J. Familial resemblance of schizotypic traits. Psychological Medicine 23 (1993) 327-333
6. Berenbaum H., and Oltmanns T.F. Emotional experience and expression in schizophrenia and depression. Journal of Abnormal Psychology 101 (1992) 37-44
7. Bergman-Jungestrom M., and Wingren S. Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women. British Journal of Cancer 85 (2001) 859-862
8. Bilder R.M., Volavka J., Czobor P., Malhotra A.K., Kennedy J.L., Ni X., et al. Neurocognitive correlates of the COMT Val (158) Met polymorphism in chronic schizophrenia. Biological Psychiatry 52 (2002) 701-707
9. Bilder R.M., Volavka J., Lachman H.M., and Grace A.A. The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29 (2004) 1943-1961
10. Blanchard J.J., Gangestad S.W., Brown S.A., and Horan W.P. Hedonic capacity and schizotypy revisited: A taxometric analysis of social anhedonia. Journal of Abnormal Psychology 109 (2000) 87-95
11. Blanchard J.J., Horan W.P., and Brown S.A. Diagnostic differences in social anhedonia: A longitudinal study of schizophrenia and major depressive disorder. Journal of Abnormal Psychology 110 (2001) 363-371
12. Butcher J.N., Graham J.R., Ben-Porath Y.S., Tellegen A., Dahlstrom W.G., and Kaemmer B. Minnesota Multiphasic Personality Inventory-2: Manual for administration and scoring. Rev. ed. (2001), University of Minnesota Press, Minneapolis
13. Calkins M.E., Curtis C.E., Grove W.M., and Iacono W.G. Multiple dimensions of schizotypy in first degree biological relatives of schizophrenia patients. Schizophrenia Bulletin 30 (2004) 317-325
14. Callicott J.H., Mattay V.S., Verchinski B.A., Marenco S., Egan M.F., and Weinberger D.R. Complexity of prefrontal cortical dysfunction in schizophrenia: More than up or down. American Journal of Psychiatry 160 (2003) 2209-2215
15. Chapman, L. J., & Chapman, J. P. (1983). Infrequency Scale. Unpublished test.
16. Chapman L.J., Chapman J.P., Kwapil T.R., Eckblad M., and Zinser M.C. Putatively psychosis-prone subjects 10 years later. Journal of Abnormal Psychology 103 (1994) 171-183
17. Chapman L.J., Chapman J.P., and Raulin M.L. Scales for physical and social anhedonia. Journal of Abnormal Psychology 85 (1976) 374-382
18. Chapman L.J., Chapman J.P., and Raulin M.L. Body-image aberration in schizophrenia. Journal of Abnormal Psychology 87 (1978) 399-407
19. Chen W.J., Hsiao C.K., and Lin C.C. Schizotypy in community samples: The three-factor structure and correlation with sustained attention. Journal of Abnormal Psychology 106 (1997) 649-654
20. Chen X., Wang X., O'Neill A.F., Walsh D., and Kendler K.S. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Molecular Psychiatry 9 (2004) 962-967
21. Clementz B.A., Grove W.M., Katsanis J., and Iacono W.G. Psychometric detection of schizotypy: Perceptual aberration and physical anhedonia in relatives of schizophrenics. Journal of Abnormal Psychology 100 (1991) 607-612
22. Cohen J. Statistical power analysis for the behavioral sciences. rev. ed. (1977), Academic Press, New York
23. Dunham I., Collins J., Wadey R., and Scambler P. Possible role for COMT in psychosis associated with velo-cardio-facial syndrome. Lancet 340 (1992) 1361-1362
24. Eckblad M., and Chapman L.J. Magical ideation as an indicator of schizotypy. Journal of Consulting and Clinical Psychology 51 (1983) 215-225
25. Eckblad, M., Chapman, L. J., Chapman, J. P., & Mishlove, M. (1982). The Revised Social Anhedonia Scale. Unpublished test.
26. Egan M.F., Goldberg T.E., Gscheidle T., Weirich M., Rawlings R., Hyde T.M., et al. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biological Psychiatry 50 (2001) 98-107
27. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences, USA 98 (2001) 6917-6922
28. Ekselius L., Lindstrom E., von Knorring L., Bodlund O., and Kullgren G. SCID II interviews and the SCID screen questionnaire as diagnostic tools for personality disorders in DSM-III-R. Acta Psychiatrica Scandinavica 90 (1994) 120-123
29. Enoch M.A., Xu K., Ferro E., Harris C.R., and Goldman D. Genetic origins of anxiety in women: A role for a functional catechol-O-methyltransferase polymorphism. Psychiatric Genetics 13 (2003) 33-41
30. Etain B., Roy I., Henry C., Rousseva A., Schurhoff F., Leboyer M., et al. No evidence for physical anhedonia as a candidate symptom or an endophenotype in bipolar affective disorder. Bipolar Disorders 9 (2007) 706-712
31. Fan J.B., Chen W.Y., Tang J.X., Li S., Gu N.F., Feng G.Y., et al. Family-based association studies of COMT gene polymorphisms and schizophrenia in the Chinese population. Molecular Psychiatry 7 (2002) 446-447
32. Fanous A., Gardner C., Walsh D., and Kendler K.S. Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in nonpsychotic relatives. Archives of General Psychiatry 58 (2007) 669-673
33. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., and Smith Benjamin L. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) (1997), American Psychiatric Press, Washington, DC
34. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) (1997), American Psychiatric Press, Washington, DC
35. Glatt S.J., Chayavichitsilp P., Depp C., Schork N.J., and Jeste D.V. Successful aging: From phenotype to genotype. Biological Psychiatry 62 (2007) 282-293
36. Glatt S.J., Faraone S.V., and Tsuang M.T. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: Meta-analysis of case-control and family-based studies. American Journal of Psychiatry 160 (2003) 469-476
37. Goghari V.M., and Sponheim S.R. Divergent backward masking performance in schizophrenia and bipolar disorder: Association with COMT. American Journal of Medical Genetics: Neuropsychiatric Genetics 147 B (2008) 223-227
38. Goldberg T.E., Egan M.F., Gscheidle T., Coppola R., Weickert T., Kolachana B.S., et al. Executive subprocesses in working memory: Relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Archives of General Psychiatry 60 (2003) 889-896
39. Gooding D.C., and Braun J.G. Visuoconstructive performance, implicit hemispatial inattention, and schizotypy. Schizophrenia Research 68 (2004) 261-269
40. Grove W.M., Lebow B.S., Clementz B.A., Cerri A., Medus C., and Iacono W.G. Familial prevalence and coaggregation of schizotypy indicators: A multitrait family study. Journal of Abnormal Psychology 100 (1991) 115-121
41. Horan W.P., Blanchard J.J., Gangestad S.W., and Kwapil T.R. The psychometric detection of schizotypy: Do putative schizotypy indicators identify the same latent class?. Journal of Abnormal Psychology 113 (2004) 339-357
42. Horan W.P., Brown S.A., and Blanchard J.J. Social anhedonia and schizotypy: The contribution of individual differences in affective traits, stress, and coping. Psychiatry Research 149 (2007) 147-156
43. Horan W.P., Reise S.P., Subotnik K.L., Ventura J., and Nuechterlein K.H. The validity of psychosis proneness scales as vulnerability indicators in recent-onset schizophrenia patients. Schizophrenia Research 100 (2008) 224-236
44. Katsanis J., Iacono W.G., and Beiser M. Anhedonia and perceptual aberration in first-episode psychotic patients and their relatives. Journal of Abnormal Psychology 99 (1990) 202-206
45. Kendler K.S., Lieberman J.A., and Walsh D. The Structured Interview for Schizotypy (SIS): A preliminary report. Schizophrenia Bulletin 15 (1989) 559-571
46. Kendler K.S., Thacker L., and Walsh D. Self-report measures of schizotypy as indices of familial vulnerability to schizophrenia. Schizophrenia Bulletin 22 (1996) 511-520
47. Kerns J.G. Schizotypy facets, cognitive control, and emotion. Journal of Abnormal Psychology 115 (2006) 418-427
48. Kwapil T.R. Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders. Journal of Abnormal Psychology 107 (1998) 558-565
49. Lachman H., Morrow B., Shprintzen R., Veit S., Parsia S., Faedda G., et al. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. American Journal of Medical Genetics 67 (1996) 468-472
50. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., and Weissman M.M. Best estimate of lifetime psychiatric diagnosis: A methodological study. Archives of General Psychiatry 39 (1982) 879-883
51. Lenzenweger M.F. Schizotaxia, schizotypy, and schizophrenia: Paul E. Meehl's blueprint for the experimental psychopathology and genetics of schizophrenia. Journal of Abnormal Psychology 115 (2006) 195-200
52. Li T., Vallada H., Curtis D., Arranz M., Xu K., Cai G., et al. Catechol-O-methyltransferase Val158Met polymorphism: Frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics 7 (1997) 349-353
53. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melen K., Julkunen I., et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34 (1995) 4202-4210
54. Ma X., Sun J., Yao J., Wang Q., Hu X., Deng W., et al. A quantitative association study between schizotypal traits and COMT, PRODH and BDNF genes in a healthy Chinese population. Psychiatry Research 153 (2007) 7-15
55. 158Met and executive control: A test of the benefit of specific deficits to translational research. Journal of Abnormal Psychology 116 (2007) 306-312
56. McIntosh A.M., Job D.E., Moorhead W.J., Harrison L.K., Whalley H.C., Johnstone E.C., et al. Genetic liability to schizophrenia or bipolar disorder and its relationship to brain structure. American Journal of Medical Genetics: Neuropsychiatric Genetics 141 B (2006) 76-83
57. Meehl P.E. Schizotaxia revisited. Archives of General Psychiatry 46 (1989) 935-944
58. Meehl P.E. Primary and secondary hypohedonia. Journal of Abnormal Psychology 110 (2001) 188-193
59. Meyer-Lindenberg A., Miletich R.S., Kohn P.D., Esposito G., Carson R.E., Quarantelli M., et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nature Neuroscience 5 (2002) 267-271
60. Miller L.S., and Burns S.A. Gender differences in schizotypic features in a large sample of young adults. Journal of Nervous and Mental Disease 183 (1995) 657-661
61. Moreau J.L., Borgulya J., Jenck F., and Martin J.R. Tolcapone: A potential new antidepressant detected in a novel animal model of depression. Behavioral Pharmacology 5 (1994) 344-350
62. Mynett-Johnson L.A., Murphy V.E., Claffey E., Shields D.C., and McKeon P. Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatric Genetics 8 (1998) 221-225
63. Nolan K.A., Bilder R.M., Lachman H.M., and Volavka J. Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: Differential effects of Val and Met alleles on cognitive stability and flexibility. American Journal of Psychiatry 161 (2004) 359-361
64. Park S., and McTigue K. Working memory and the syndromes of schizotypal personality. Schizophrenia Research 26 (1997) 213-220
65. Raine A. The SPQ: A scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophrenia Bulletin 17 (1991) 555-564
66. Rosa A., Peralta V., Cuesta M.J., Zarzuela A., Serrano F., Martínez-Larrea A., et al. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. American Journal of Psychiatry 161 (2004) 1110-1112
67. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: Implications for psychiatric genetics. American Journal of Psychiatry 165 (2008) 420-423
68. Schurhoff F., Szoke A., Chevalier F., Roy I., Meary A., Bellivier F., et al. Schizotypal dimensions: An intermediate phenotype associated with the COMT high activity allele. American Journal of Medical Genetics: Neuropsychiatric Genetics 144 B (2007) 64-68
69. Siessmeier T., Kienast T., Wrase J., Larsen J.L., Braus D.F., Smolka M.N., et al. Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli. European Journal of Neuroscience 24 (2006) 305-313
70. Slifstein M., Kolachana B., Simpson E.H., Tabares P., Cheng B., Duvall M., et al. COMT genotype predicts cortical-limbic D1 receptor availabillity measured with [11C]NNC112 and PET. Molecular Psychiatry 13 (2008) 821-827
71. Smyrnis N., Avramopoulos D., Evdokimidis I., Stefanis C.N., Tsekou H., and Stefanis N.C. Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men. Biological Psychiatry 61 (2007) 845-853
72. Sponheim S.R., Steele V.R., and McGuire K.A. Verbal memory processes in schizophrenia patients and biological relatives of schizophrenia patients: Intact implicit memory, impaired explicit recollection. Schizophrenia Research 71 (2004) 339-348
73. Stefanis N.C., Van Os J., Avramopoulos D., Smyrnis N., Evdokimidis I., Hantoumi I., et al. Variation in catechol-o-methyltransferase val158 met genotype associated with schizotypy but not cognition: A population study in 543 young men. Biological Psychiatry 56 (2004) 510-515
74. Thaker G.K., Wonodi I., Avila M.T., Hong L.E., and Stine O.C. Catechol O-methyltransferase polymorphism and eye tracking in schizophrenia: A preliminary report. American Journal of Psychiatry 161 (2004) 230-232
75. Tunbridge E., Harrison P., and Weinberger D. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biological Psychiatry 60 (2006) 141-151
76. Venables, N. C., Bernat, E. M., & Sponheim, S. R. (in press). Genetic and disorder specific aspects of resting state EEG abnormalities in schizophrenia. Schizophrenia Bulletin
77. Weinberger D.R., Berman K., and Chase T. Mesocortical dopaminergic function and human cognition. Annals of the New York Academy of Sciences 537 (1988) 330-338
78. Wonodi I., Stine O.C., Mitchell B.D., Buchanan R.W., and Thaker G.K. Association between Val108/158 Met polymorphism of the COMT gene and schizophrenia. American Journal of Medical Genetics: Neuropsychiatric Genetics 120 B (2003) 47-50
79. Woo J.M., Yoon K.S., Choi Y.H., Oh K.S., Lee Y.S., and Yu B.H. The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. Journal of Psychiatric Research 38 (2004) 365-370
80. Zubieta J., Heitzeg M., Smith Y., Bueller J., Xu K., Xu Y., et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299 (2003, February 21) 1240-1243